Table 1 Baseline demographic and clinical characteristics of RA patients treated with infliximab
Arm A (3 mg/kg) (n  =  71)Arm B (5 mg/kg) (n  =  69)
Age, mean years (SD)45.6 (13.2)48.1 (13.3)
Gender, female/male, %67/3369/31
Disease duration, mean years (SD)13.0 (8.1)12.9 (8.4)
Glucocorticoids52%51%
Baseline DAS28, at study randomisation; mean DAS28 (SD)4.5 (1.1)4.5 (1.2)
Swollen joints, mean count (SD)4.8 (3.6)4.5 (3.6)
Methotrexate dose, mean dose (SD)14.2 (4.9)14.1 (4.7)
Infliximab dose in the study, mg/kg; mean dose (SD)3.4 (0.5)5.1 (0.5)
  • DAS28, disease activity score in 28 joints; RA, rheumatoid arthritis; SD, standard deviation.